Q9NZQ7 (PD1L1_HUMAN) Homo sapiens (Human)

Programmed cell death 1 ligand 1 UniProtKBInterProSTRINGInteractive Modelling

290 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; )

Sequence Features

 239-259Helical.
 40-114
 155-209
 29-124Immunoglobulin V-set domain
IPR013106PF07686
 147-219CD80-like, immunoglobulin C2-set
IPR013162PF08205

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRangeDownloadAssess
Crystal structure of human PD-L1 with monoclonal antibody avelumab Heteromer
5grj18-233
Crystal structure of human PD-L1 in complex with high affinity PD-1 mutant Heteromer
Q15116;
CL;5ius18-231
CRYSTAL STRUCTURE OF HUMAN PD-L1 Heteromer
Q9NZQ7;
CL;4z1819-230
Crystal Structure of the PD-1/PD-L1 Complex Heteromer
Q02242;
3bik18-229
Structure of PD-L1 Heteromer
Q9NZQ7;
5jdr19-230
'Crystal structure of the complex between the extracellular domains of mouse PD-1 mutant and huma... Heteromer
Q02242;
3sbw19-229
PD-L1 in complex with durvalumab Heteromer
5x8m18-133
PD-L1 in complex with BMS-936559 Fab Heteromer
5ggt18-133
PD-L1 in complex with atezolizumab Heteromer
5x8l18-133
Crystal structure of PD-L1 complexed with a nanobody at 1.7 Angstron resolution Heteromer
NA;SO4;CL;5jds18-132
Structure of the complex of human programmed death-1 (PD-1) and its ligand PD-L1. Heteromer
Q15116;
NA;4zqk18-132
Crystal structure of PD-L1 complexed with atezolizumab fab at 2.9A Heteromer
5xxy18-132
Structure of PD-L1/small-molecule inhibitor complexhomo-4-mer 8J8;5n2d18-134
Dimeric Structure of PD-L1homo-2-mer 3fn319-232
PD-L1 IgV domain V76T with fragmenthomo-2-mer SO4;6np918-134
Structure of PD-L1/small-molecule inhibitor complexhomo-2-mer 8HW;5n2f18-134
'Structure of human Programmed cell death 1 ligand 1 (PD-L1) with low molecular mass inhibitor'homo-2-mer 8YZ;EDO;5niu18-134
'Structure of human Programmed cell death 1 ligand 1 (PD-L1) with low molecular mass inhibitor'homo-2-mer 6GX;5j8918-134
'Structure of human Programmed cell death 1 ligand 1 (PD-L1) with low molecular mass inhibitor'homo-2-mer JQT;EDO;6r3k18-134
'Structure of human Programmed cell death 1 ligand 1 (PD-L1) with low molecular mass inhibitor'homo-2-mer 6GZ;5j8o18-134
PD-L1 IgV domain V76T with fragmenthomo-2-mer KW7;6noj18-134
PD-L1 IgV domain V76T with fragmenthomo-2-mer KWA;6nos18-134
PD-L1 IgV domain bound to fragmenthomo-2-mer 22L;6nm719-134
IgV-V76T BMS compound 105homo-2-mer KSD;6nm819-134
Crystal Structure of the PD-L1monomer 3bis19-230
Complex structure of durvalumab-scFv/PD-L1monomer 5xj419-228
Structure of human PD-L1 in complex with inhibitormonomer 5o4517-134
PD-1 binding domain from human PD-L1monomer 5c3t18-134
PD-L1 IgV domain complex with macro-cyclic peptidemonomer 6nnv18-134
Structure of human PD-L1 in complex with inhibitormonomer 5o4y18-132

Homology models built on isoform sequence

Isoform #Oligo-stateLigandsQMEANTemplateRangeSeq id (%)ReportDownloadAssess
2monomer3sbw.1.B13-115
96.43
3monomer6cnk.1.F18-174
15.69
3monomer6fgo.1.C18-173
15.11
3monomer3bis.2.A18-177
100.00